Health

Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...

2020-06-01 07:30 2630

Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...

2020-06-01 07:30 1927

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...

2020-06-01 07:30 1859

(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company presented fo...

2020-05-31 20:00 2327

Fosun Foundation and Longfor Group donated 40 ventilators to the U.S. hospitals in fight against COVID-19

NEW YORK, May 29, 2020 /PRNewswire/ -- Fosun Foundation together with Longfor Group announce the donation of 40 Breas Vivo 50 ventilators to the hospitals in 21 hospitals located in 11 different states of U.S. to support medical communities fighting againse the COVID-19. The donated 40 ventila...

2020-05-30 02:00 2912

I-Mab Announces Upcoming Participation at June Conferences

SHANGHAI and GAITHERSBURG, Md., May 29, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical ...

2020-05-29 20:00 6163

Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO)

SUZHOU, China and SHANGHAI, May 29, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, today announced that two presentations were accepted at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program. ...

2020-05-29 20:00 2110

Mundane Glory: Telling the Story of Chinese Overseas Medical Aid

CHANGSHA, China, May 29, 2020 /PRNewswire/ -- Aired in Mango TV, Mundane Glory is a series of short documentary that focuses on strivers who work on Chinese emerging industry. It has been aired in global platforms including Mango TV and Hunan Satellite TV sinceMay 21st of this year.

2020-05-29 17:41 1785

WorkJam Launches Next-Generation Health Check Analysis Tool, Advancing the Safety of Frontline Workforces

Industry-leading digital workplace platform introduces new tool to reduce the spread of COVID-19 among frontline employees and their customers MONTREAL, May 28, 2020 /PRNewswire/ -- WorkJam, the leading digital workplace solutions provider for organizations with frontline employees, today announc...

2020-05-28 21:00 2051

Seaweed Extract Offers Hope for Influenza A

CAMBRIDGE, Australia, May 28, 2020 /PRNewswire/ --  Australian scientists have revealed that a natural compound found in seaweed may reduce the effects of severe cases of Influenza A. Fucoidan is a highly bioactive compound found naturally in brown seaweed and well known for its diverse therapeu...

2020-05-28 15:30 1176

IntegriCulture Inc. Closes Series A Fundraising Round Led by Beyond Next Ventures at JPY800 Million

TOKYO, May 28, 2020 /PRNewswire/ -- IntegriCulture Inc. has completed a Series A fundraising round ofJPY800 million (USD7.4 million) backed by Beyond Next Ventures, NH Foods, AgFunder and other investors. The cumulative amount raised stands aboutJPY1.1 billion (USD10.2 million). (Logo: https://...

2020-05-28 13:00 2144

Shanghai Cell Therapy Group Launches Collaboration with USC researcher to Improve the ex vivo Expansion of Hematopoietic Stem Cells for Clinical Applications

SHANGHAI, May 27, 2020 /PRNewswire/ -- Shanghai Cell Therapy Group (SHCell) recently entered into a six-year research collaborative project with Professor Qi-Long Ying from theUniversity of Southern California (USC). Through the project, sponsored by$3.6 million from the Baize Plan Fund, the Ying...

2020-05-28 10:35 1222

I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome

SHANGHAI and GAITHERSBURG, MD, May 27, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced interim results from a multi-center, double blinded, randomized, placeb...

2020-05-28 04:05 1869

Transcenta Presents First Data from Phase 1 Study of pH-Dependent PDL1 Antibody MSB2311 in Patients with Pre-treated Advanced Solid Tumors and Select Hematological Malignancies

SUZHOU, China, May 27, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery,development and manufacturing of antibody-based therapeutics, announced today results reported for the first time from a Phase 1...

2020-05-27 23:00 1227

Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference

AUSTIN, May 27, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that President and Chief Executive Officer,Cameron Reynolds has been invited to present at The Role of Cell Therapy and Clarity on Testing Conference organised by the Maxim Group. Event Det...

2020-05-27 20:45 10027

IT Tech Packaging, Inc. Signs Letter of Intent to Acquire Intelligent Healthcare IT Solution Provider

BAODING, China, May 27, 2020 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE MKT: ITP) ("IT Tech Packaging" or "the Company"), a leading manufacturer and distributor of diversified paper products inNorth China, today announced that its operating entity inChina, Hebei Baoding Dongfang Paper Milling ...

2020-05-27 20:00 10685

United Imaging uMR OMEGA Cleared by FDA, Available in U.S. Market

HOUSTON, May 26, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced U.S. Food & Drug Administration (FDA) clearance of the uMR OMEGATM magnetic resonance imaging (MRI) scanner. The uMR OMEGA offers the world's first ultra-wide 75...

2020-05-26 20:00 1534

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

AMBLER, Pa., May 25, 2020 /PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S of Denmark to create and develop bispecific antibodies using Genmab's Du...

2020-05-25 22:00 1551

VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock

AUSTIN, Texas, May 22, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to hel...

2020-05-23 04:01 11314

Mayne Pharma launches BAC 300 capsules in the United States

ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg inthe United States. Mayne Pharma received approval from the US Food and Drug Administration for its Abb...

2020-05-22 13:44 5640
1 ... 257258259260261262263 ... 280